Alector, Inc. (ALEC) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$24.39M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$24.92M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$37.61M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$34.14M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$24.39M | (m) | $3.32M | (m) | $31.00K* | -$34.22M* | (m) | $19.46M | (m) | $130.00K |
| 2026-03-31 | Reported | (m) | -$24.92M | (m) | $1.05M | (m) | $118.00K | -$49.81M | (m) | $17.86M | (m) | $0.00 |
| 2025-09-30 | Reported | (m) | -$37.61M | (m) | $3.26M | (m) | $11.00K* | -$32.51M* | (m) | $29.35M | (m) | $0.00 |
| 2025-06-30 | Reported | (m) | -$34.14M | (m) | $7.87M | (m) | $10.00K* | -$49.05M* | (m) | $27.61M | (m) | $0.00 |
| 2025-03-31 | Reported | (m) | -$44.70M | (m) | $3.67M | (m) | $20.00K | -$60.78M | (m) | $33.64M | (m) | $0.00 |
| 2024-09-30 | Reported | (m) | -$48.43M | (m) | $15.34M | (m) | $212.00K* | -$50.73M* | (m) | $48.00M | (m) | $0.00 |
| 2024-06-30 | Reported | (m) | -$45.61M | (m) | $15.08M | (m) | $337.00K* | -$62.80M* | (m) | $46.31M | (m) | $73.00K |
| 2024-03-31 | Reported | (m) | -$43.71M | (m) | $15.89M | (m) | $533.00K | -$61.35M | (m) | $45.17M | (m) | $7.00K |
| 2023-09-30 | Reported | (m) | -$50.58M | (m) | $9.11M | (m) | -$94.00K* | -$46.54M* | (m) | $46.33M | (m) | $1.25M |
| 2023-06-30 | Reported | (m) | -$3.59M | (m) | $56.21M | (m) | $1.22M* | -$43.00M* | (m) | $46.18M | (m) | $1.39M |
| 2023-03-31 | Reported | (m) | -$50.12M | (m) | $16.55M | (m) | $1.02M | -$48.55M | (m) | $51.89M | (m) | $901.00K |
| 2022-09-30 | Reported | (m) | -$47.75M | (m) | $14.85M | (m) | $1.92M* | -$49.05M* | (m) | $48.35M | (m) | $733.00K |
| 2022-06-30 | Reported | (m) | $9.47M | (m) | $79.85M | (m) | $744.00K* | -$57.44M* | (m) | $54.53M | (m) | $1.04M |
| 2022-03-31 | Reported | (m) | -$44.12M | (m) | $24.47M | (m) | $692.00K | $135.09M | (m) | $53.04M | (m) | $758.00K |
| 2021-09-30 | Reported | (m) | $126.33M | (m) | $182.41M | (m) | $915.00K* | $445.05M* | (m) | $43.07M | (m) | $0.00 |
| 2021-06-30 | Reported | (m) | -$55.33M | (m) | $6.57M | (m) | $828.00K* | -$44.54M* | (m) | $47.82M | (m) | $0.00 |
| 2021-03-31 | Reported | (m) | -$52.63M | (m) | $4.11M | (m) | $947.00K | -$52.69M | (m) | $45.73M | (m) | $0.00 |
| 2020-09-30 | Reported | (m) | -$53.75M | (m) | $5.90M | (m) | $381.00K* | -$40.82M* | (m) | $43.82M | (m) | (m) |
| 2020-06-30 | Reported | (m) | -$46.59M | (m) | $3.17M | (m) | $297.00K* | -$45.94M* | (m) | $34.06M | (m) | (m) |
| 2020-03-31 | Reported | (m) | -$42.08M | (m) | $7.17M | (m) | $3.57M | -$32.31M | (m) | $34.60M | (m) | (m) |
| 2019-12-31 | Reported | (m) | -$32.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | Reported | (m) | -$34.15M | (m) | $2.70M | (m) | $2.30M* | -$28.86M* | (m) | $28.52M | (m) | (m) |
| 2019-06-30 | Reported | (m) | -$27.15M | (m) | $6.92M | (m) | $9.36M* | -$18.05M* | (m) | $25.64M | (m) | (m) |
| 2019-03-31 | Reported | (m) | -$20.76M | (m) | $5.61M | (m) | $2.03M | -$23.57M | (m) | $20.61M | (m) | (m) |
| 2018-12-31 | Reported | (m) | -$19.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | Reported | (m) | -$16.82M | (m) | $6.50M | (m) | $157.00K* | -$22.36M* | (m) | $20.39M | (m) | (m) |
| 2018-06-30 | Reported | (m) | -$12.23M | (m) | $7.11M | (m) | $697.00K* | -$17.05M* | (m) | $16.82M | (m) | (m) |
| 2018-03-31 | Reported | (m) | -$9.22M | (m) | $4.75M | (m) | $613.00K | $184.53M | (m) | $11.72M | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$156.01M | (m) | $21.05M | (m) | $41.00K | -$184.03M | (m) | $123.06M | (m) | $168.00K |
| 2024-12-31 | Reported | (m) | -$145.00M | (m) | $100.56M | (m) | $1.25M | -$229.91M | (m) | $185.94M | (m) | $128.00K |
| 2023-12-31 | Reported | (m) | -$151.74M | (m) | $97.06M | (m) | $2.38M | -$184.16M | (m) | $192.12M | (m) | $5.21M |
| 2022-12-31 | Reported | (m) | -$137.83M | (m) | $133.62M | (m) | $4.12M | -$20.33M | (m) | $210.42M | (m) | $3.25M |
| 2021-12-31 | Reported | (m) | -$37.36M | (m) | $207.09M | (m) | $3.25M | $298.55M | (m) | $189.41M | (m) | $0.00 |
| 2020-12-31 | Reported | (m) | -$195.17M | (m) | $21.10M | (m) | $5.03M | -$166.73M | (m) | $156.87M | (m) | $0.00 |
| 2020-09-30 | Rolling | (m) | -$174.76M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | Rolling | (m) | -$155.16M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | Rolling | (m) | -$135.72M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | Reported | (m) | -$114.40M | (m) | $21.22M | (m) | $15.27M | -$99.31M | (m) | $100.53M | (m) | $0.00 |
| 2019-12-31 | Rolling | (m) | -$114.40M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | Rolling | (m) | -$101.08M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | Rolling | (m) | -$83.75M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | Rolling | (m) | -$68.82M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | Reported | (m) | -$57.29M | (m) | $27.51M | (m) | $1.88M | $127.46M | (m) | $73.03M | (m) | (m) |
| 2018-12-31 | Rolling | (m) | -$57.29M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | Reported | (m) | -$32.68M | (m) | $2.87M | (m) | $801.00K | -$17.77M | (m) | $29.91M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |